These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2897559)

  • 21. Once-daily therapy with ceftriaxone compared with daily multiple-dose therapy with cefotaxime for serious bacterial infections: a randomized, double-blind study.
    Mandell LA; Bergeron MG; Ronald AR; Vega C; Harding G; Saginur R; Feld R; Duperval R; Landis SJ; Miedzinski LJ
    J Infect Dis; 1989 Sep; 160(3):433-41. PubMed ID: 2668427
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of ceftriaxone in the treatment of community-acquired pneumonia in adult hospital patients. A pharmaco-economic study based on a meta-analysis.
    Wessels F; Anderson AN; Ebrahim O
    S Afr Med J; 1998 Mar; 88(3):251-5. PubMed ID: 9608289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized monocentric trial in febrile neutropenic patients: ceftriaxone and gentamicin vs cefepime and gentamicin.
    Cornely OA; Bethe U; Seifert H; Breuer K; Schütt-Gerowitt H; Salzberger B; Schrappe M; Fätkenheuer G
    Ann Hematol; 2002 Jan; 81(1):37-43. PubMed ID: 11807634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cefuroxime versus ceftriaxone prophylaxis in cardiovascular surgery.
    Geroulanos S; Donfried B; Schumacher F; Turina M
    Drugs Exp Clin Res; 1985; 11(3):201-5. PubMed ID: 3915287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Once-daily dosing regimen for aminoglycoside plus beta-lactam combination therapy of serious bacterial infections: comparative trial with netilmicin plus ceftriaxone.
    ter Braak EW; de Vries PJ; Bouter KP; van der Vegt SG; Dorrestein GC; Nortier JW; van Dijk A; Verkooyen RP; Verbrugh HA
    Am J Med; 1990 Jul; 89(1):58-66. PubMed ID: 2195890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomised, multicentre study of ceftriaxone versus standard therapy in the treatment of lower respiratory tract infections.
    de Klerk GJ; van Steijn JH; Lobatto S; Jaspers CA; van Veldhuizen WC; Hensing CA; Bunnik MC; Geraedts WH; Dofferhof AS; Van Den Berg J; Melis JH; Hoepelman AI
    Int J Antimicrob Agents; 1999 Jul; 12(2):121-7. PubMed ID: 10418756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ceftriaxone is twice as cost-effective as standard therapy in biliary tract infection.
    Zoepf T; Jakobs R; Riemann JF
    Hepatogastroenterology; 2004; 51(58):941-5. PubMed ID: 15239219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Once daily ceftriaxone and gentamicin for the treatment of febrile neutropenia.
    Tomlinson RJ; Ronghe M; Goodbourne C; Price C; Lilleyman JS; Das S; Saha V
    Arch Dis Child; 1999 Feb; 80(2):125-31. PubMed ID: 10325726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy, tolerability, and cost savings associated with the use of open-label metronidazole plus ceftriaxone once daily compared with ticarcillin/clavulanate every 6 hours as empiric treatment for diabetic lower-extremity infections in older males.
    Clay PG; Graham MR; Lindsey CC; Lamp KC; Freeman C; Glaros A
    Am J Geriatr Pharmacother; 2004 Sep; 2(3):181-9. PubMed ID: 15561650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Single-dose ceftriaxone versus multiple-dose cefuroxime for prophylaxis of surgical site infection].
    Li ZL; Tong SX; Yu BM; Tang WS; Wu ZY; Wang SB; Wu YF; Lu WQ; Luo M; Wang J
    Zhonghua Wai Ke Za Zhi; 2003 May; 41(5):372-4. PubMed ID: 12892594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Ceftriaxone in the treatment of staphylococcal endocarditis].
    Demin AA; Drobysheva VP
    Antibiot Khimioter; 1998; 43(6):12-5. PubMed ID: 9644528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized study of sequential intravenous/oral moxifloxacin in comparison to sequential intravenous ceftriaxone/oral cefuroxime axetil in patients with hospital-acquired pneumonia.
    Höffken G; Barth J; Rubinstein E; Beckmann H;
    Infection; 2007 Dec; 35(6):414-20. PubMed ID: 18034211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients.
    Cornelissen JJ; de Graeff A; Verdonck LF; Branger T; Rozenberg-Arska M; Verhoef J; Dekker AW
    Antimicrob Agents Chemother; 1992 Apr; 36(4):801-7. PubMed ID: 1503442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
    Gorschlüter M; Hahn C; Fixson A; Mey U; Ziske C; Molitor E; Horré R; Sauerbruch T; Marklein G; Schmidt-Wolf IG; Glasmacher A
    Support Care Cancer; 2003 Jun; 11(6):362-70. PubMed ID: 12690546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Community-based treatment of serious bacterial infections in newborns and young infants: a randomized controlled trial assessing three antibiotic regimens.
    Zaidi AK; Tikmani SS; Warraich HJ; Darmstadt GL; Bhutta ZA; Sultana S; Thaver D
    Pediatr Infect Dis J; 2012 Jul; 31(7):667-72. PubMed ID: 22481421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of ceftriaxone and cefuroxime for perioperative prophylaxis in orthopedic surgery.
    Meyer JM
    Am J Surg; 1984 Oct; 148(4A):27-9. PubMed ID: 6091477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients.
    de Pauw BE; Kauw F; Muytjens H; Williams KJ; Bothof T
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():93-9. PubMed ID: 6311790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term antibiotic prophylaxis in open urologic surgery.
    Pacelli F; Ceriati F; Bellantone R; Cavicchioni C
    J Chemother; 1990 Aug; 2(4):257-9. PubMed ID: 2230911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An assessment of the hidden and total antibiotic costs of four parenteral cephalosporins.
    Smyth ET; Barr JG; O'Neill CA; Hogg GM
    Pharmacoeconomics; 1995 Dec; 8(6):541-50. PubMed ID: 10160082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prospective and comparative study between cefuroxime, ceftriaxone and amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia].
    Sánchez ME; Gómez J; Gómez Vargas J; Baños V; Ruiz Gómez J; Muñoz L; Simarro E; Soto MC; Canteras M; Valdés M
    Rev Esp Quimioter; 1998 Jun; 11(2):132-8. PubMed ID: 9795298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.